Bass, Berry & Sims represents Mallinckrodt Pharmaceuticals in numerous separate opioid cases filed in state courts across Tennessee, Virginia and Kentucky. One of the Tennessee cases is a precedent-setting, opioid-related case for the country; it is presently on appeal to the Tennessee Supreme Court upon the appellate court’s reversal of a grant of a dispositive motion to our client. A second case was set to go to trial at the time of a recent bankruptcy filing involving a global settlement of opioid claims that stayed the case as to our client.
Mallinckrodt Pharmaceuticals (NYSE: MNK) is a primarily generic pharmaceutical manufacturer of opioids.